- Home
- Advocacy
- Laboratory Oversight and Regulation
- Laboratory-Developed Test Oversight
A US District Court judge on March 31 nullified the Food and Drug Administration (FDA) regulation on the oversight of laboratory-developed tests (LDTs), agreeing with plaintiffs' and the College of American Pathologists' (CAP) arguments that the rule should be vacated.